AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
This is not about replacing Verilog. It’s about evolving the hardware development stack so engineers can operate at the level of intent, not just implementation.